Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03003897 · ClinicalTrials.gov registry record
Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.
A clinical trial, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- 609
- Enrollment target
NCT03003897 is a clinical trial that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 609 participants.
The verdict
NCT03003897 has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- 609 participants
- Enrollment target
Study Summary
Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in overweight and obese individuals. The investigators will evaluate results of randomized controlled trials (RCTs) of soluble fiber supplementation among overweight and obese adults for outcomes related to weight management (e.g. body mass index \[BMI\], body weight, body fat percentage, waist circumference) and glucose and insulin homeostasis (e.g. fasting glucose, homeostasis model assessment of insulin resistance \[HOMA-IR\], fasting insulin) through systematic review and meta-analysis.
Interventions
- OTHER Placebo
- OTHER Soluble Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 609 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03003897
The ClinicalTrials.gov registry entry for NCT03003897 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 609 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03003897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03003897 about?
NCT03003897 is a clinical study titled "Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.". Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in over...
What is the current status of trial NCT03003897?
This trial is currently completed. The enrollment target is 609 participants. The study started on 2016-01. Estimated completion is 2017-10.
What interventions are being tested in trial NCT03003897?
The interventions under investigation include: Placebo (OTHER), Soluble Fiber (OTHER).
Who is sponsoring clinical trial NCT03003897?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.